Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
about
Recommendations for preclinical research in hemorrhagic transformationIdentification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screeningAdult stem cell transplantation: is gender a factor in stemness?Performance measures for in-hospital care of acute ischemic stroke in public hospitals in Chile.Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model.Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model.Stem Cell-Induced Biobridges as Possible Tools to Aid Neuroreconstruction after CNS Injury.Safety and improvement of movement function after stroke with atomoxetine: A pilot randomized trial.The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South IndiaStroke service: how can we improve and measure outcomes? Consensus summary from a global stroke forum.Organic nanoparticles with aggregation-induced emission for tracking bone marrow stromal cells in the rat ischemic stroke model.Organic Nanoparticles with Aggregation-Induced Emission for Bone Marrow Stromal Cell Tracking in a Rat PTI Model.Cost-saving innovations for acute ischemic stroke and transient ischemic attack.Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs.Stroke networks and telemedicine: An Italian national survey.
P2860
Q27024324-A54BB70C-E52C-4E9F-BC8A-F3D7CB32F341Q28538569-89498CFE-E35A-4BF6-B0D2-1CA7A9DC5A83Q34358408-BFF70B4F-61EC-4097-9C9A-1D0EAD27195EQ34622040-9287EB1B-8C19-467A-B476-802C95B70B74Q34653099-8D0F0CCA-2643-40BF-B929-C4A77D5337CCQ35675476-1EC03AEB-9D65-4C10-B0F4-1E154F69D835Q36379561-395230A0-91F2-4C79-8514-A81DD259FD17Q37635604-132D3809-64EC-472F-A727-E5722A34ED50Q37686191-1860CF72-FFFD-435A-BF5E-2C190FBBBF91Q38209361-89AF75E5-97F5-4C5E-89B5-00648B2973EBQ48506198-E4F53C02-5058-4E5D-9C2E-86B781A9D1FDQ48531859-E2E3535C-417F-452D-9398-7F11E63A4999Q49381531-CF2C1BDB-91D9-442D-9711-82443B8A7B94Q52148119-365D5090-A3D4-45AC-B4D3-6BE62A99ED8DQ55044193-D15F3785-9CED-4976-8501-FD801B1C5374
P2860
Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimizing the management of a ...... e plasminogen activator (tPA).
@en
type
label
Optimizing the management of a ...... e plasminogen activator (tPA).
@en
prefLabel
Optimizing the management of a ...... e plasminogen activator (tPA).
@en
P2860
P1476
Optimizing the management of a ...... e plasminogen activator (tPA).
@en
P2860
P304
P356
10.1111/J.1365-2710.2012.01366.X
P577
2012-06-19T00:00:00Z